Ascendis Pharma (ASND) PT Raised to $195 at Wedbush
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $253.29 -0.6%
Rating Summary:
22 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
22 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Wedbush analyst Liana Moussatos raised the price target on Ascendis Pharma (NASDAQ: ASND) to $195.00 (from $164.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BMO Capital Starts Ascendis Pharma (ASND) at Outperform
- Deere (DE) PT Raised to $585 at JPMorgan
- Alibaba (9988:HK) (BABA) PT Raised to HK$188.70 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
